We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

353 hedge funds and large institutions have $5.72B invested in Ionis Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 112 increasing their positions, 119 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 43

4% more funds holding

Funds holding: 339 → 353 (+14)

6% less repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 119

11% less capital invested

Capital invested by funds: $6.45B → $5.72B (-$735M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

35% less call options, than puts

Call options by funds: $78.8M | Put options by funds: $120M

Holders
353
Holders Change
+14
Holders Change %
+4.13%
% of All Funds
9.51%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
58
Increased
112
Reduced
119
Closed
43
Calls
$78.8M
Puts
$120M
Net Calls
-$41.7M
Net Calls Change
-$37.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$36.1M
2
CS
Credit Suisse
Switzerland
+$30.3M
3
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
+$29.1M
4
First Trust Advisors
First Trust Advisors
Illinois
+$25M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$24.7M

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$126M
2
BA
BlackRock Advisors
Delaware
-$50.1M
3
EAM
Eagle Asset Management
Florida
-$46.5M
4
State Street
State Street
Massachusetts
-$42.6M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$42.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
URS
176
Utah Retirement Systems
Utah
$1.23M +$1.35M +21,300 New
Nomura Asset Management
177
Nomura Asset Management
Japan
$1.22M -$318K -5,000 -19%
PCM
178
Perkins Capital Management
Minnesota
$1.21M -$111K -1,750 -8%
DCM
179
Dupont Capital Management
Delaware
$1.14M -$151K -2,370 -11%
Parallax Volatility Advisers
180
Parallax Volatility Advisers
California
$1.11M +$1.23M +19,356 New
MOACM
181
Mutual of America Capital Management
New York
$1.09M -$2.55M -40,167 -68%
Creative Planning
182
Creative Planning
Kansas
$1.07M +$444K +6,982 +60%
FSA
183
Franklin Street Advisors
North Carolina
$1.07M – – –
Canada Life
184
Canada Life
Manitoba, Canada
$1.07M – – –
BCM
185
BlueCrest Capital Management
Jersey
$1M +$1.11M +17,414 New
HK
186
Horizon Kinetics
New York
$978K – – –
PWM
187
Perigon Wealth Management
California
$958K – – –
SIA
188
Starfire Investment Advisers
Michigan
$952K – – –
TD Asset Management
189
TD Asset Management
Ontario, Canada
$944K +$82.7K +1,300 +9%
Credit Agricole
190
Credit Agricole
France
$935K +$69.9K +1,100 +7%
DADC
191
D.A. Davidson & Co
Montana
$931K +$42.2K +664 +4%
BCB
192
Brian C. Broderick
$902K – – –
NCCM
193
Nine Chapters Capital Management
New Jersey
$898K +$992K +15,600 New
NFA
194
Nationwide Fund Advisors
Ohio
$865K -$5.73M -90,073 -86%
GAM
195
Gotham Asset Management
New York
$854K +$442K +6,947 +88%
ZIM
196
Zacks Investment Management
Illinois
$828K +$91.3K +1,436 +11%
Mitsubishi UFJ Asset Management
197
Mitsubishi UFJ Asset Management
Japan
$817K -$48.5K -762 -5%
NCA
198
NCM Capital Advisers
North Carolina
$817K – – –
CA
199
Commerzbank Aktiengesellschaft
Germany
$815K +$118K +1,848 +15%
NMIMC
200
Northwestern Mutual Investment Management Company
Wisconsin
$811K +$896K +14,090 New
6 7
8
9 10

IONS Hedge Fund Activity: Q2 2015 in Review

353 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2015, worth a combined $5.72B — down 11% from $6.45B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new IONS positions and 43 closed out — a net gain of 15 holders — while 112 added to existing stakes and 119 trimmed.

The largest buyer was Vanguard Group, adding an estimated $36.1M. The largest seller was BlackRock Fund Advisors, cutting an estimated $126M.

  • 353 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2015, up from 339 in Q1 2015.
  • Funds reported $5.72B of Ionis Pharmaceuticals stock for Q2 2015, down 11% quarter-over-quarter.
  • 58 funds opened new Ionis Pharmaceuticals positions in Q2 2015 and 43 closed out, a net change of +15 holders.
  • The largest Ionis Pharmaceuticals buyer in Q2 2015 was Vanguard Group, an estimated $36.1M added.
  • The largest Ionis Pharmaceuticals seller in Q2 2015 was BlackRock Fund Advisors, an estimated $126M sold.

Based on aggregated 13F filings for Q2 2015.